Join our team in a dynamic hybrid role, offering flexibility to work remotely and from our headquarters in Watertown, MA. Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. Disc Medicine values collaboration, professional development, and scientific integrity and promotes an inclusive company culture that empowers and inspires. As Disc Medicine evolves from a clinical stage to commercial stage organization, the Company has a new role for a Director/Sr. Director of Small Molecule Product Development. The successful candidate will be instrumental in driving the company's growth trajectory and achieving strategic objectives. The Director/Sr. Director of Small Molecule Chemical Development will be responsible for working on CDMO activities related to technology transfer, development, optimization, scale-up, development manufacture, and commercial manufacture of small molecule drug products and related materials. There will be a significant contribution expected from this role to enable regulatory filings of Disc Medicine assets. This position requires a minimum of 10 years of industry experience developing drug products for small molecule drug substances in the pharmaceutical industry.